Clinical use of oral laxatives in palliative care services in Spain

Supportive Care in Cancer

Volumn 18, Issue 11, 2010, Pages 1491-1494

  Noguera, Antonio ^a   Centeno, Carlos ^b   Librada, Silvia ^c   Nabal, María ^d  

^a Hospital Centro de Cuidados Laguna   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c Extremadura Health Service   (Spain)

^d HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

Author keywords

Constipation; Laxatives; Palliative care

Indexed keywords

DOCUSATE SODIUM; ENEMA; LACTITOL; LACTULOSE; LAXATIVE; MACROGOL; MAGNESIUM SALT; OPIATE; OPIATE DERIVATIVE; OSMOTIC AGENT; PARAFFIN; POLYPHENOL; SENNOSIDE; NARCOTIC ANALGESIC AGENT;

AGED; ARTICLE; CONSTIPATION; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DESCRIPTIVE RESEARCH; DRUG EFFICACY; DRUG USE; FEMALE; FUNCTIONAL STATUS; HUMAN; INTESTINAL DYSMOTILITY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPAIN; CLINICAL TRIAL; DRUG COMBINATION; METHODOLOGY; NEOPLASM; ORAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ANALGESICS, OPIOID; CATHARTICS; CONSTIPATION; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; ENEMA; FEMALE; HUMANS; LAXATIVES; MALE; NEOPLASMS; PALLIATIVE CARE; PROSPECTIVE STUDIES; SPAIN; TREATMENT OUTCOME;

EID: 79952116783     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-010-0956-0     Document Type: Article

References (17)

1. Laugsad EA, Kaasa S, de Conno F, Hanks G, Klepstad P (2009) Research steering committee of the EAPC. J OpioidManag 5:11-21
2. Noguera A, Centeno C, Librada S, Nabal M (2009) Screening for constipation in palliative care patients. J Palliat Med 12:915-920
3. Braiteh F, El Osta B, Palmer JL, Reddy SK, Bruera E (2007) Characteristics, findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center. J Palliat Med 10:948-955
4. Clemens KE, Klaschik E (2008) Management of constipation in palliative care patients. Curr Opin Support Palliat Care 2:22-27
5. Sykes NP (1996) A volunteer model for the comparison of laxatives in opioid-related constipation. J Pain Symptom Manage 11:363-369
6. Sykes N (1994) Current approaches to the management of constipation. Cancer Surv 21:137-146
7. Larkin PJ, Sykes NP, Centeno C, Ellersaw J, Elsner F (2008) The management of constipation in palliative care: Clinical practice recommendations. Palliat Med 22:796-807
8. Miles CL, Fellowes D, Goodman ML, Wilkinson S (2006) Laxatives for the management of constipation in palliative care patients. Cochrane Database of Systematic Reviews; Issue 4. Art No.: CD003448. doi 10.1002/14651858. CD003448.pub2.
9. Bennett M, Cresswell H (2003) Factors influencing constipation in advanced cancer patients: A prospective study of opioid dose, dantron dose and physical functioning. Palliative Medicine 5:418-22
10. Goodman M, Low J, Wilkinson S (2005) Constipation management in palliative care: A survey of practices in United Kingdom. J Pain Symptom Manage 29:238-244
11. Droney J, Ross J, Gretton S, Welsh K, Sato H, Riley J (2008) Constipation in cancer patients on morphine. Support Care Cancer 16:453-459
12. Davis MP (2008) Cancer constipation: Are opioids really the culprit? Support Care Cancer 16:427-429
13. Hawley PH, Byeon JJ (2008) A comparison of sennosides-based bowel protocols with and without docusate in hospitalized patients with cancer. J Palliat Med 11:575-581
14. Wirz S, Klaschick E (2005) Management of constipation in palliative care patients undergoing opioid therapy: Is polyethylene glycol an option? Am J Hosp Palliat Care 22:375-381
15. Thomas J, Karver S, Cooney GA, Chamberlain BH, Watt CK, Slatkin NE (2008) Methylnatrexone for opioid-induced constipation in advanced illness. N Engl J Med 358:2332-2343
16. Chamberlain BH, Cross K, Winston JL, Thomas J, Wang W, Su C, Israel LJ (2009) Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness. J Pain Symptom Manage 38:683-690
17. Moss J, Rosow CE (2008) Development of peripheral opioid antagonists: New insights into opioid effects. Mayo Clin Proc 83:1116-1130